Viaken Secures $13 Million in Second Round Funding | GenomeWeb

NEW YORK, June 25 – Bioinformatics provider Viaken Systems of Gaithersburg, Md., said Monday it has closed $13 million in second-round equity funding. 

Sterling Venture Partners was the lead investor, along with new participating investors MacAndrews & Forbes, Allianz, Schoffstall Ventures, and E-media, and repeat investors Core Capital Partners and Mid-Atlantic Venture Funds. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.